What is the expected growth forecast for the AI in Diagnostics market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing adoption.

What are the key drivers of the AI in Diagnostics market?

Key drivers include rising demand for accurate diagnostics and growing investments in AI technologies.

What are the major challenges facing the AI in Diagnostics market?

Challenges include data privacy concerns, regulatory hurdles, and high development costs.

Which regions are expected to lead the AI in Diagnostics market?

North America and Europe are expected to dominate the market due to high adoption rates.

Who are the top companies in the AI in Diagnostics market?

Top companies include IBM, Google, and Microsoft, which are investing heavily in AI technologies.

What are the future opportunities in the AI in Diagnostics market?

Future opportunities include increasing use of AI in medical imaging and growing demand for personalized medicine.

How will technology impact the AI in Diagnostics market?

Advances in machine learning and natural language processing will drive growth and innovation in the market.

What is the current regulatory landscape for the AI in Diagnostics market?

The regulatory landscape is evolving, with governments implementing guidelines for AI development and deployment.

What is the future outlook for the AI in Diagnostics market?

The future outlook is positive, with increasing adoption and investment in AI technologies driving market growth.

Artificial Intelligence (AI) in Diagnostics Market Report 2026: Analyst-Verified Data & Forecast

Artificial Intelligence (AI) in Diagnostics by Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), by Types (Software, Hardware), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.1%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Artificial Intelligence (AI) in Diagnostics Market Size | CAGR 25.1 Forecast 2033

Artificial Intelligence (AI) in Diagnostics Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.1%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Intelligence (AI) in Diagnostics Market Overview

The Artificial Intelligence (AI) in Diagnostics market refers to the application of AI technologies in medical diagnostics, enabling healthcare professionals to make more accurate and efficient diagnoses. As the AI in Diagnostics market size is expected to reach $3.7 billion by 2026, the growth outlook and market forecast indicate a significant industry expansion driven by the increasing adoption of AI-powered diagnostic tools. The scope of this market encompasses various diagnostic applications, including image analysis, clinical decision support systems, and predictive analytics, which are transforming the healthcare landscape.

Loading chart…

The current Artificial Intelligence (AI) in Diagnostics market size is expected to grow at a CAGR of 30.5% during the forecast period, driven by macro drivers such as the increasing demand for accurate diagnoses, cost-effective solutions, and personalized medicine. Key forces shaping the industry include technology shifts towards more advanced AI algorithms, regulations supporting the adoption of AI in healthcare, and consumer behavior driving the demand for more efficient and effective diagnostic solutions. The largest region in the AI in Diagnostics market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing adoption of AI-powered diagnostic tools in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	7.20 billion
Growth rate	CAGR of 25.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aidoc Medical Ltd.; AliveCor; GE Healthcare; IDx Technologies; Imagen Technologies; NovaSignal Corporation; Riverain Technologies, LLC; Siemens Healthineers; VUNO, Inc.; Zebra Medical Vision Ltd.; Canon; Subtle Medical; DeepMind; Samsung Healthcare; Koninklijke Philips N.V.; Butterfly Network
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artificial Intelligence (AI) in Diagnostics market is poised for significant growth, driven by increasing demand for accurate and efficient diagnostic solutions. The Artificial Intelligence (AI) in Diagnostics market size is expected to expand rapidly, with a substantial growth forecast over the next few years.

Growth Drivers2 items

Advances in machine learning algorithms and deep learning techniques are enabling the development of more sophisticated AI-powered diagnostic tools, driving growth in the Artificial Intelligence (AI) in Diagnostics market

Increasing adoption of electronic health records and other digital health technologies is creating new opportunities for AI-powered diagnostics, contributing to the growth forecast of the Artificial Intelligence (AI) in Diagnostics market

Restraints2 items

High development costs and regulatory hurdles are limiting the widespread adoption of AI-powered diagnostic solutions, restraining the growth of the Artificial Intelligence (AI) in Diagnostics market size

Concerns over data privacy and security are also hindering the growth of the Artificial Intelligence (AI) in Diagnostics market, as healthcare organizations are cautious about adopting new technologies that involve sensitive patient data

Opportunities2 items

The increasing prevalence of chronic diseases is creating new opportunities for AI-powered diagnostics, as healthcare providers seek to improve patient outcomes and reduce costs, driving growth in the Artificial Intelligence (AI) in Diagnostics market

The growing demand for personalized medicine is also driving the adoption of AI-powered diagnostic tools, as healthcare providers seek to tailor treatment plans to individual patients' needs, contributing to the growth forecast of the Artificial Intelligence (AI) in Diagnostics market

Challenges2 items

The lack of standardization in AI-powered diagnostic solutions is creating challenges for healthcare providers, as they seek to integrate these tools into their existing workflows, limiting the growth of the Artificial Intelligence (AI) in Diagnostics market size

The need for ongoing training and validation of AI-powered diagnostic models is also a significant challenge, as healthcare providers must ensure that these tools remain accurate and effective over time, affecting the Artificial Intelligence (AI) in Diagnostics market growth forecast

Market Segmentation

Loading chart…

The Application segment in the Artificial Intelligence (AI) in Diagnostics market refers to the various use cases where AI is utilized to improve diagnostic accuracy and efficiency. This segment contributes significantly to the overall market size, as it encompasses a wide range of applications, including image analysis, clinical decision support, and predictive analytics. The Artificial Intelligence (AI) in Diagnostics segmentation by application is a critical aspect of market taxonomy, as it helps stakeholders understand the diverse needs and opportunities within the industry.

The Types segment in the Artificial Intelligence (AI) in Diagnostics market is categorized into subtypes, such as deep learning, machine learning, and natural language processing. Each subtype has its unique characteristics and applications, contributing to the overall market size. For instance, deep learning techniques are widely used in image analysis applications, while machine learning algorithms are often employed in clinical decision support systems. Understanding the different types of AI in diagnostics is essential for developing effective market strategies and identifying potential growth opportunities in the Artificial Intelligence (AI) in Diagnostics market.

Artificial Intelligence (AI) in Diagnostics Segmentation Breakdown8 items

Application

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Others

Types

Software

Hardware

Regional Insights

Loading chart…

The Artificial Intelligence (AI) in Diagnostics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of AI technologies, favorable policies, and significant investments in the healthcare sector.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large patient population. Europe is driven by demographics, with an aging population and an increased need for efficient diagnostic solutions. Asia Pacific is fueled by investments in AI research, a growing ecosystem, and government initiatives to promote AI adoption in healthcare. Latin America and Middle East & Africa are driven by increasing adoption of AI technologies and growing infrastructure development.

The regional forecast indicates that the Asia Pacific region will experience significant Artificial Intelligence (AI) in Diagnostics market growth, with a compound annual growth rate (CAGR) of 25%. This growth is attributed to the increasing adoption of AI-powered diagnostic tools, rising investments in healthcare infrastructure, and favorable government policies supporting the development of AI technologies.

Competitive Landscape

The Artificial Intelligence (AI) in Diagnostics competitive landscape is moderately consolidated, with a mix of global players and local companies vying for market share. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of global players with extensive resources and local companies with strong regional presence, leading to a dynamic Artificial Intelligence (AI) in Diagnostics competitive landscape.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Aidoc Medical Ltd. - regional expansion

AliveCor - premium pricing

GE Healthcare - innovation pipeline

IDx Technologies - OEM tie-ups

Imagen Technologies - local manufacturing

NovaSignal Corporation - vertical integration

Key Artificial Intelligence (AI) in Diagnostics Companies16 items

Aidoc Medical Ltd.

AliveCor

GE Healthcare

IDx Technologies

Imagen Technologies

NovaSignal Corporation

Riverain Technologies, LLC

Siemens Healthineers

VUNO, Inc.

Zebra Medical Vision Ltd.

Canon

Subtle Medical

DeepMind

Samsung Healthcare

Koninklijke Philips N.V.

Butterfly Network

Market Ecosystem

The Artificial Intelligence (AI) in Diagnostics ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as technology providers supply AI solutions to integrators, who then incorporate these solutions into diagnostic systems for channels to distribute to end users.

Technology providers — develop AI algorithms and software

System integrators / EPCs — integrate AI into diagnostic systems

Distributors / channel partners — supply diagnostic systems to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize diagnostic systems in healthcare settings

Regulators/standards bodies — establish standards and approvals for AI in diagnostics

Data/analytics providers — provide data management and analytics services

In the Artificial Intelligence (AI) in Diagnostics ecosystem, control points are primarily held by regulators and standards bodies, as their approvals and standards influence the adoption of AI solutions. Dependency risks arise from input constraints, such as data quality, and standards, which can impact the performance of AI algorithms. Switching costs and partnerships are also crucial, as they can affect the interoperability of diagnostic systems and AI solutions. The ecosystem may differ by region due to varying regulatory frameworks and healthcare infrastructure, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Artificial Intelligence (AI) in Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between tech giants and healthcare providers have accelerated the adoption of AI-powered diagnostic tools. Notable mergers and acquisitions have also taken place, with companies like Google and Microsoft investing heavily in AI-driven healthcare startups. Furthermore, several product and technology launches have been announced, including AI-based imaging and diagnostic platforms.

Additionally, regulatory changes have paved the way for increased AI adoption in diagnostics, with the FDA approving several AI-powered medical devices. A shift in consumer trends has also been observed, with patients increasingly expecting personalized and precise diagnostic results. The industry has also seen significant funding rounds and expansions, with venture capital firms investing heavily in AI-driven diagnostic startups, further fueling the growth of the Artificial Intelligence (AI) in Diagnostics industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Artificial Intelligence (AI) in Diagnostics market outlook. The market attractiveness is high due to the increasing demand for accurate and efficient diagnostic solutions. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead. The long-term outlook is positive, driven by advancements in machine learning and deep learning technologies.

The innovation landscape is rapidly evolving, with new applications of AI in diagnostics emerging continuously. The demand-supply balance is expected to shift in favor of demand, driven by the growing need for AI-powered diagnostic solutions. However, key risk factors such as data privacy and regulatory challenges need to be addressed to ensure sustainable growth in the Artificial Intelligence (AI) in Diagnostics market.

11 items

1. Executive Summary

2. Artificial Intelligence (AI) in Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Intelligence (AI) in Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Artificial Intelligence (AI) in Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.1.3. Diagnostic Centers

6.1.4. Others

6.2. Global Artificial Intelligence (AI) in Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Software

6.2.2. Hardware

6.3. Global Artificial Intelligence (AI) in Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Artificial Intelligence (AI) in Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Intelligence (AI) in Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Intelligence (AI) in Diagnostics Market Competition by Key Manufacturers

8.1. Global Artificial Intelligence (AI) in Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Artificial Intelligence (AI) in Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Aidoc Medical Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. AliveCor

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. GE Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. IDx Technologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Imagen Technologies

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. NovaSignal Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Riverain Technologies, LLC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Siemens Healthineers

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. VUNO, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Zebra Medical Vision Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Canon

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Subtle Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. DeepMind

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Samsung Healthcare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Koninklijke Philips N.V.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Butterfly Network

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Intelligence (AI) in Diagnostics Market

Figure 4: Global Artificial Intelligence (AI) in Diagnostics Market: Drivers

Figure 5: Global Artificial Intelligence (AI) in Diagnostics Market: Challenges

Figure 6: Global Artificial Intelligence (AI) in Diagnostics Market: Trends

Figure 7: Global Artificial Intelligence (AI) in Diagnostics Market: Opportunity

Figure 8: Global Artificial Intelligence (AI) in Diagnostics Market: Restraint

Figure 9: Global Artificial Intelligence (AI) in Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Artificial Intelligence (AI) in Diagnostics Market Value (USD Million) By Region

Figure 15: Global Artificial Intelligence (AI) in Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Artificial Intelligence (AI) in Diagnostics Market Value (USD Million) By Region

Figure 23: Global Artificial Intelligence (AI) in Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Intelligence (AI) in Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Intelligence (AI) in Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Intelligence (AI) in Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Artificial Intelligence (AI) in Diagnostics Market Value (USD Million) By Region

Table 10: Global Artificial Intelligence (AI) in Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Artificial Intelligence (AI) in Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Artificial Intelligence (AI) in Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Artificial Intelligence (AI) in Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Aidoc Medical Ltd. Basic Information And Sales Area

Table 31: Aidoc Medical Ltd.. Products Portfolio

Table 32: AliveCor Basic Information And Sales Area

Table 33: AliveCor. Products Portfolio

Table 34: GE Healthcare Basic Information And Sales Area

Table 35: GE Healthcare. Products Portfolio

Table 36: IDx Technologies Basic Information And Sales Area

Table 37: IDx Technologies. Products Portfolio

Table 38: Imagen Technologies Basic Information And Sales Area

Table 39: Imagen Technologies. Products Portfolio

Table 40: NovaSignal Corporation Basic Information And Sales Area

Table 41: NovaSignal Corporation. Products Portfolio

Table 42: Riverain Technologies, LLC Basic Information And Sales Area

Table 43: Riverain Technologies, LLC. Products Portfolio

Table 44: Siemens Healthineers Basic Information And Sales Area

Table 45: Siemens Healthineers. Products Portfolio

Table 46: VUNO, Inc. Basic Information And Sales Area

Table 47: VUNO, Inc.. Products Portfolio

Table 48: Zebra Medical Vision Ltd. Basic Information And Sales Area

Table 49: Zebra Medical Vision Ltd.. Products Portfolio

Table 50: Canon Basic Information And Sales Area

Table 51: Canon. Products Portfolio

Table 52: Subtle Medical Basic Information And Sales Area

Table 53: Subtle Medical. Products Portfolio

Table 54: DeepMind Basic Information And Sales Area

Table 55: DeepMind. Products Portfolio

Table 56: Samsung Healthcare Basic Information And Sales Area

Table 57: Samsung Healthcare. Products Portfolio

Table 58: Koninklijke Philips N.V. Basic Information And Sales Area

Table 59: Koninklijke Philips N.V.. Products Portfolio

Table 60: Butterfly Network Basic Information And Sales Area

Table 61: Butterfly Network. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Artificial Intelligence (AI) in Diagnostics Market Value (USD Million) By Region

Table 67: Global Artificial Intelligence (AI) in Diagnostics Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Artificial Intelligence (AI) in Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	7.20 billion
Growth rate	CAGR of 25.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aidoc Medical Ltd.; AliveCor; GE Healthcare; IDx Technologies; Imagen Technologies; NovaSignal Corporation; Riverain Technologies, LLC; Siemens Healthineers; VUNO, Inc.; Zebra Medical Vision Ltd.; Canon; Subtle Medical; DeepMind; Samsung Healthcare; Koninklijke Philips N.V.; Butterfly Network
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options